TACC3 and invasive ductal breast carcinoma: In contrast, Affymetrix microarray analysis has revealed that levels of TACC3 mRNA increase during the transition of breast cancer from preinvasive ductal carcinoma in situ to invasive ductal carcinoma [29], suggesting that TACC3 may impart a proliferative advantage to a subset of breast cancers.